Trade Conquest

Subscribe Now

| ATPC 0.1157 65.29% | MTEN 0.0323 -8.50% | OCG 0.0098 -16.95% | SOXS 2.065 -9.43% | AUID 2.295 131.23% | CJMB 5.0131 347.60% | IVP 0.0477 -41.83% | ZSL 2.9499 4.61% | SLV 82.9899 -1.86% | NVDA 187.4686 2.36% | SPHL 16.5703 636.46% | INTC 49.117 0.81% | APLT 0.1014 1.50% | BNKK 4.34 56.12% | DVLT 0.7402 3.06% | SOXL 60.9973 10.14% | TQQQ 55.57 3.23% | ASST 0.9927 -3.62% | BYND 1.02 6.04% | TZA 5.905 -4.14% | GRAB 4.41 -4.75% | TSLL 18.3793 1.71% | EEM 58.31 0.97% | ONDS 13.055 -3.72% | BBAI 6.375 1.84% | TSLS 5.145 -0.87% | SPY 694.78 0.64% | IBRX 3.6479 20.79% | MSTX 4.96 -4.62% | NOK 6.725 5.74% | DUST 5.775 -0.43% | AMD 236.295 5.68% | SIDU 3.595 -4.13% | RZLV 4.69 15.52% | BITO 13.39 -1.25% | IBIT 54.725 -1.29% | JTAI 0.4753 4.55% | AAL 15.765 4.13% | NVD 7.065 -4.66% | VALE 14.755 0.99% | QQQ 626.2588 1.08% | PLUG 2.34 -0.43% | SQQQ 64.7999 -3.20% | TSM 349.625 6.88% | XLF 54.585 0.80% | TSLA 443.0155 0.87% | CRWV 98.9301 10.17% | SEGG 1.0905 17.68% | CAN 0.8098 -7.46% | PTHL 0.5285 20.17%

Canaccord Genuity Raises Doximity Price Target To $67, Maintains Hold

Canaccord Genuity raised its price target on Doximity Inc. (NYSE: DOCS) to $67 from $59 while reiterating a Hold rating.

The firm noted that the rapid pace of change in the large language model (LLM) environment is reshaping healthcare technology. While scale and user adoption remain important, analysts said trust among users is critical to long-term success.

Doximity’s position in the early stages of the AI transition could allow it to become one of the winners in the space, according to the firm. However, at current valuation levels, Canaccord maintained its Hold stance despite the raised target.

Published on: September 18, 2025

More news